Oral Infigratinib Seems Safe for Children With Achondroplasia
MONDAY, Nov. 18, 2024-- For children with achondroplasia, oral infigratinib does not result in major safety signals and yields increased annualized height velocity and z score at a dose of 125 mg, according to a study published online Nov. 18 in...
Read more »